These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 29960711)
1. Risk reduction of endometrial and ovarian cancer after bisphosphonates use: A meta-analysis. Zhang XS; Zhang YM; Li B; Fan B; Zhao Y; Yang SJ Gynecol Oncol; 2018 Sep; 150(3):509-514. PubMed ID: 29960711 [TBL] [Abstract][Full Text] [Related]
2. The effect of bisphosphonates on the risk of endometrial and ovarian malignancies. Rennert G; Rennert HS; Pinchev M; Lavie O Gynecol Oncol; 2014 May; 133(2):309-13. PubMed ID: 24556062 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates and risk of cancers: a systematic review and meta-analysis. Li YY; Gao LJ; Zhang YX; Liu SJ; Cheng S; Liu YP; Jia CX Br J Cancer; 2020 Nov; 123(10):1570-1581. PubMed ID: 32901134 [TBL] [Abstract][Full Text] [Related]
4. Statin use and the risk of ovarian and endometrial cancers: a meta-analysis. Wang Y; Ren F; Song Z; Chen P; Liu S; Ouyang L BMC Cancer; 2019 Jul; 19(1):730. PubMed ID: 31340777 [TBL] [Abstract][Full Text] [Related]
5. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials. Liu Y; Qin A; Li T; Qin X; Li S Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024 [TBL] [Abstract][Full Text] [Related]
6. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. Myung SK; Ju W; Choi HJ; Kim SC; BJOG; 2009 Dec; 116(13):1697-705. PubMed ID: 19775307 [TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate use and the risk of endometrial cancer: a meta-analysis of observational studies. Ou YJ; Chiu HF; Wong YH; Yang YH Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1107-1115. PubMed ID: 27501339 [TBL] [Abstract][Full Text] [Related]
8. Oral bisphosphonate use and risk of postmenopausal endometrial cancer. Newcomb PA; Passarelli MN; Phipps AI; Anderson GL; Wactawski-Wende J; Ho GY; O'Sullivan MJ; Chlebowski RT J Clin Oncol; 2015 Apr; 33(10):1186-90. PubMed ID: 25713431 [TBL] [Abstract][Full Text] [Related]
9. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis. Siristatidis C; Sergentanis TN; Kanavidis P; Trivella M; Sotiraki M; Mavromatis I; Psaltopoulou T; Skalkidou A; Petridou ET Hum Reprod Update; 2013; 19(2):105-23. PubMed ID: 23255514 [TBL] [Abstract][Full Text] [Related]
10. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. Keum N; Greenwood DC; Lee DH; Kim R; Aune D; Ju W; Hu FB; Giovannucci EL J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25757865 [TBL] [Abstract][Full Text] [Related]
11. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis. Li J; Liu R; Tang S; Feng F; Liu C; Wang L; Zhao W; Zhang T; Yao Y; Wang X; Sun C Arch Gynecol Obstet; 2019 Jan; 299(1):35-46. PubMed ID: 30460611 [TBL] [Abstract][Full Text] [Related]
12. Risks of breast, endometrial, and ovarian cancers after twin births. Ji J; Försti A; Sundquist J; Hemminki K Endocr Relat Cancer; 2007 Sep; 14(3):703-11. PubMed ID: 17914100 [TBL] [Abstract][Full Text] [Related]
13. Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis. Peng R; Liang X; Zhang G; Yao Y; Chen Z; Pan X; Wang J; Liu G Biomed Res Int; 2020; 2020():5606573. PubMed ID: 33102580 [TBL] [Abstract][Full Text] [Related]
14. The risk of developing breast, ovarian, and endometrial cancer in obese women submitted to bariatric surgery: a meta-analysis. Ishihara BP; Farah D; Fonseca MCM; Nazario A Surg Obes Relat Dis; 2020 Oct; 16(10):1596-1602. PubMed ID: 32690459 [TBL] [Abstract][Full Text] [Related]
15. Early-life body mass index and risks of breast, endometrial, and ovarian cancers: a dose-response meta-analysis of prospective studies. Byun D; Hong S; Ryu S; Nam Y; Jang H; Cho Y; Keum N; Oh H Br J Cancer; 2022 Mar; 126(4):664-672. PubMed ID: 34773099 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Alford SH; Rattan R; Buekers TE; Munkarah AR Cancer; 2015 Feb; 121(3):441-7. PubMed ID: 25533883 [TBL] [Abstract][Full Text] [Related]
17. Dietary acrylamide intake and risk of women's cancers: a systematic review and meta-analysis of prospective cohort studies. Benisi-Kohansal S; Salari-Moghaddam A; Seyed Rohani Z; Esmaillzadeh A Br J Nutr; 2021 Nov; 126(9):1355-1363. PubMed ID: 33413725 [TBL] [Abstract][Full Text] [Related]
18. Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Poole EM; Lin WT; Kvaskoff M; De Vivo I; Terry KL; Missmer SA Cancer Causes Control; 2017 May; 28(5):437-445. PubMed ID: 28299512 [TBL] [Abstract][Full Text] [Related]
19. Coffee Decreases the Risk of Endometrial Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies. Lafranconi A; Micek A; Galvano F; Rossetti S; Del Pup L; Berretta M; Facchini G Nutrients; 2017 Nov; 9(11):. PubMed ID: 29120352 [TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Zhou B; Yang L; Sun Q; Cong R; Gu H; Tang N; Zhu H; Wang B Am J Med; 2008 Jun; 121(6):501-508.e3. PubMed ID: 18501231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]